While human ameloblastomas harbor driver mutations in the mitogen-activated protein kinase (MAPK) pathway (including BRAF, KRAS, NRAS, HRAS and FGFR4) and Hedgehog pathway (SMO)11,12, the drivers of CAA have not been known. This evidence concerns the gene HRAS and ameloblastoma.